Winthrop Capital Management’s Medtronic MDT Stock Holding History

Winthrop Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Hold	18	–	–	﹤0.01%	321
2026 Q1	$2K	Hold	18	–	–	﹤0.01%	283
2025 Q4	$2K	Sell	18 -325	-95%	-$31.6K	﹤0.01%	291
2025 Q3	$33K	Sell	343 -7,481	-96%	-$688K	0.01%	187
2025 Q2	$682K	Sell	7,824 -21	-0.3%	-$1.78K	0.17%	82
2025 Q1	$705K	Buy	7,845 +316	+4%	+$28.3K	0.19%	80
2024 Q4	$599K	Buy	7,529 +803	+12%	+$69.5K	0.16%	89
2024 Q3	$606K	Buy	6,726 +431	+7%	+$36.3K	0.29%	45
2024 Q2	$495K	Sell	6,295 -1,439	-19%	-$118K	0.25%	43
2024 Q1	$674K	Buy	7,734 +95	+1%	+$8.11K	0.31%	45
2023 Q4	$629K	Buy	+7,639	New	+$582K	0.21%	86

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Winthrop Capital Management's MDT Position: Q2 2026 in Review

Winthrop Capital Management held its Medtronic (MDT) position steady in Q2 2026 at 18 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #321.

Winthrop Capital Management first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $705K in Q1 2025. 2,124 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Winthrop Capital Management held 18 shares of Medtronic worth $1K as of Q2 2026.
Winthrop Capital Management left its Medtronic share count unchanged in Q2 2026.
Medtronic made up ﹤0.01% of Winthrop Capital Management's portfolio in Q2 2026, its #321 holding.
Winthrop Capital Management first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
Winthrop Capital Management's Medtronic position peaked at $705K in Q1 2025.
2,124 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.